I. WHAT IS TELEMEDICINE?
Telemedicine is the fastest growing alternative health care delivery option in the United States, demonstrating a growth of 53% between 2016-17 compared to urgent care centers (increase of 14%), retail clinics (increase of 7%), ambulatory surgical centers (“ASCs”) (increase of 6%), and emergency departments (decrease of 2%).Footnote 1 According to a report by Global Market Insights, Inc. the U.S. telemedicine market is expected to reach $64 billion by 2025.Footnote 2 In order to understand telemedicine's attractiveness as an option for delivering health care, it is important to first understand how telemedicine is defined.
The American Telemedicine Association (“ATA”)Footnote 3 defines “telemedicine” as “the remote delivery of health care services and clinical information using telecommunications technology.”Footnote 4 Further, the ATA explains that telemedicine “includes a wide array of clinical services using internet, wireless, satellite and telephone media.”Footnote 5 The organization recognizes that “telemedicine” and “telehealth” can generally be used interchangeably.Footnote 6 Other organizations have given distinct definitions for “telemedicine” and “telehealth”.Footnote 7 For the purpose of consistency throughout this article, the term “telemedicine” will be used.
In order to have a more comprehensive understanding of telemedicine, it is helpful to be familiar with the different types of services that can be delivered utilizing telemedicine. The ATA has identified several types of medical services that can be provided by telemedicine.Footnote 8 These include: primary care and specialist referral services, remote patient monitoring, consumer medical and health information, and medical education.Footnote 9 Telemedicine may be used in consultations between a primary care physician and specialists at a remote location in order to make a diagnosis for a patient.Footnote 10 “This may involve the use of live interactive video or the use of store and forward transmission of diagnostic images, vital signs and/or video clips along with patient data for later review.”Footnote 11 Remote patient monitoring allows collection of the patient's medical data for interpretation by a home health agency or a remote diagnostic testing facility (“RDTF”).Footnote 12 “Such applications might include a specific vital sign, such as blood glucose or heart ECG or a variety of indicators for homebound patients.”Footnote 13 The third category of services recognized by ATA is when consumer medical and health information involves the use of technology such as the internet or wireless devices in order to obtain “specialized health information”.Footnote 14 Additionally, this category of services includes consumers' use of online discussion groups.Footnote 15 Finally, telemedicine can be used for medical information by allowing for access to continuing medical education (“CME”) for medical professionals remotely.Footnote 16
II. DEFINING ONLINE PRESCRIBING
“Online prescribing” or “internet prescribing” can generally be defined as “a provider prescribing a drug to a patient based upon an interaction that has taken place online.”Footnote 17 This must be distinguished from “e-prescribing” which is “the act of a provider sending a prescription electronically to a pharmacy, such as through an EHR, and should not be confused with online or internet prescribing.”Footnote 18 This article will only focus on online or internet prescribing. For purposes of consistency, the term “online prescribing” will be used.
A variety of issues are raised with the use of online prescribing, primarily involving the patient-provider relationship.Footnote 19 There is concern that the use of online prescribing in the telemedicine context could be problematic if there is no requirement of a prior in-person patient-provider interaction resulting in prescription decisions being made based solely on an online patient-provider relationship.Footnote 20 In a purely online relationship, some concerns are whether the patient's medical information and history are adequate and whether or not the patient is the person being represented as needing medical care.Footnote 21 These issues have led states to take different approaches to incorporating online prescribing into law which will be explored in a later section.
III. UNDERSTANDING THE DIRECT-TO-CONSUMER TELEMEDICINE OPTION
The concept of direct-to-consumer (“DTC”) began in the pharmaceutical industry and progressed to an approach to health care delivery.Footnote 22 The use of DTC is distinguished from other ways of providing telemedicine by the initiation of the encounter by the patient.Footnote 23 “Direct to consumer telemedicine, specifically, can be carried out in one of three ways: (1) between a patient and a provider with whom they have an established relationship, (2) between a patient and another provider from a practice where the patient has an established relationship, or (3) from a provider with whom they have no pre-established relationship.”Footnote 24 The last category of DTC has seen the greatest increase of the three in the past five years.Footnote 25 Additionally, DTC has been recognized as the “most popular” method of using telemedicine.Footnote 26
It is often the case that information from a DTC encounter is provided to the patient's primary care provider.Footnote 27 Even within DTC telemedicine, there are multiple ways of providing care.Footnote 28 This is explained as follows:
The types of DTC telemedicine are either synchronous, involving real-time two-way video conferencing or audio-only encounters, or asynchronous, where information is transferred between patient and provider over hours or days. Asynchronous telemedicine, also referred to as “store-and-forward” or “e-consults,” can be achieved via secure text messaging or email, and also involves the transfer of images, audio, or other multimedia files. Prescriptions may be provided whether the encounter is synchronous or asynchronous, depending on the information collected and the condition being treated. Both types of encounters are initiated with the creation of an online account, completion of a health history, and description of current symptoms. Asynchronous visits rely more on logic-based questioning and clinical decision support tools. Answers are typically reviewed by the physician through a secure portal, and a determination is made as to whether a prescription can be provided or there is not enough information. There are DTC companies, such as Lemonaid, which treat certain conditions through the use of a computer assisted algorithm only. A physician is not alerted unless certain criteria are met based on the computer-based screening. These companies are largely under regulated.Footnote 29
It is important to have this context in considering the issues surrounding telemedicine and online prescribing, and relevant research studies will be discussed in the next section. Additionally, prescribing has become a common feature of DTC telemedicine,Footnote 30 and has quickly grown in the telemedicine market.Footnote 31 More and more DTC use is being expanded into retailers as most recently seen with CVSFootnote 32, Rite Aid,Footnote 33 Amazon,Footnote 34 and Wal-GreensFootnote 35 which are now pursuing the DTC market.
IV. CURRENT RESEARCH ON TELEMEDICINE USE AND OVERPRESCRIBING
As individuals become more susceptible to antibiotic resistant infections, concerns have been raised that overprescribing of antibiotics could further fuel continued growth of antibiotic resistance.Footnote 36 There is a specific concern that telemedicine could ultimately become a culprit in antibiotic resistance due to overprescribing.Footnote 37 A number of recent research studies have demonstrated a correlation between the use of telemedicine for the delivery of health care services and overprescribing of antibiotics.Footnote 38 Most recently, more light has been shed on the issue of overprescribing in DTC telemedicine involving children, as described in an April 2019 Pediatrics article.Footnote 39 The study found that children who were seen at a DTC telemedicine provider were prescribed antibiotics for respiratory infections at a rate of 52% compared to 42% at urgent care and 31% at primary care physician (“PCP”) visits.Footnote 40 Additionally, the study found evidence that diagnoses were frequently made without adhering to the proper prescribing criteria.Footnote 41
Other research has demonstrated evidence of overprescribing in telemedicine encounters involving adults.Footnote 42 One study documented telemedicine encounters between January 2013 and August 2016 where individuals had respiratory tract infections (“RTIs”) and sought treatment for care using a DTC telemedicine option in particular.Footnote 43 The study was limited to the extent that only one format of DTC was utilized and the actual need for prescribing antibiotics was not evaluated.Footnote 44 However, the research concluded that where antibiotics were prescribed for RTIs in this DTC context, the appointment times were shortened compared to those where antibiotics were not prescribed.Footnote 45 The study ultimately suggested that the short length of telemedicine counters, which the telemedicine market depends upon for sustainability, increases the likelihood of overprescribing.Footnote 46 The authors made recommendations for physicians to carefully examine symptoms and for patients not to be hesitant to ask questions in this context even if it means lengthening the visit.Footnote 47 The article summarized, “because telemedicine encounters are short and physicians are often reimbursed by encounter volume, antibiotic stewardship efforts that lengthen visits even slightly may be difficult to implement.”Footnote 48
A 2015 RAND study evaluated the rate of prescribing between telemedicine and regular face-to-face physician visits and found virtually no difference between occurrences of prescribing in the telemedicine context compared to face-to-face physician visits.Footnote 49 The study examined DTC use involving Teledoc through the California Public Employees' Retirement System between April 2012 to October 2013 for individuals seeking medical care for acute respiratory illnesses (“ARIs”) for one or more visit.Footnote 50 The study concluded that prescribing in both the telemedicine setting of Teledoc and physician offices was similar, though in both instances there was evidence of inappropriate prescribing.Footnote 51 Additionally, prescribing in the Teledoc context was shown to involve the use of broader spectrum antibiotics compared to those treated in the face-to-face context.Footnote 52
Collectively, these research studies suggest problems with prescribing in the DTC telemedicine context, in particular with the potential for overprescribing and inappropriate prescribing. More research is needed to evaluate this trend and prescribing involving telemedicine outside of the DTC context. With the understanding of this research as background, the way in which online prescribing is regulated by law when telemedicine is utilized to deliver health care becomes critical. The following two sections will explore the current legal landscape for telemedicine and online prescribing.
V. FEDERAL LAW AND REGULATION OF ONLINE PRESCRIBING
A. Ryan Haight Online Pharmacy Consumer Protection Act of 2008
Federal law plays a significant role in the regulation of online prescribing, particularly involving controlled substances. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (“the RH Act”) was passed to regulate online prescribing regarding controlled substances.Footnote 53 The RH Act specifically amended Section 309 of the Controlled Substances Act to require a valid prescription for a controlled substance to be dispensed through the internet.Footnote 54 A “valid prescription” is defined as follows:
(A) The term ‘valid prescription’ means a prescription that is issued for a legitimate medical purpose in the usual course of professional practice by—
a practitioner who has conducted at least 1 in-person medical evaluation of the patient; or
a covering practitioner.Footnote 55
In explaining the term “a covering practitioner”, it becomes clear that telemedicine can be utilized in order to fulfill the “valid prescription” requirement as the Act states:
(C) The term ‘covering practitioner’ means, with respect to a patient, a practitioner who conducts a medical evaluation (other than an in-person medical evaluation) at the request of a practitioner who—
has conducted at least 1 in-person medical evaluation of the patient or an evaluation of the patient through the practice of telemedicine, within the previous 24 months; and
is temporarily unavailable to conduct the evaluation of the patient.Footnote 56
Thus, the RH Act provides an in-person examination requirement must be met unless one of the exceptions for the “practice of telemedicine” can be satisfied.Footnote 57 Additionally, Section 102 of the Controlled Substances Act was amended under the RH Act to include a definition for the term “practice of telemedicine.”Footnote 58 Generally, this definition provides the circumstances under which telemedicine may be used where it is permissible to engage in online prescribing. Further, the RH Act provided for several exceptions to the requirement of an in-person examination before online prescribing even when telemedicine is being used.Footnote 59 One of the most significant exceptions that was included in the RH Act was the creation of a “special registration” which was to be promulgated by the Drug Enforcement Agency (“DEA”) of the U.S. Department of Justice (“DOJ”) to allow health care providers to use telemedicine for online prescribing without the in-person examination requirement.Footnote 60 The special registration exception of the RH Act has essentially been left dormant since the law's original enactment.Footnote 61 However, more recent federal legislation passed by the Trump Administration as described below again called for the special registration to be implemented in light of the U.S. opioid crisis.Footnote 62
B. Impact of the Opioid Crisis: Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018
A major issue that has emerged with greater urgency since the passage of the RH Act has been the lack of available health care providers to treat those with mental health conditions.Footnote 63 This led to the belief that telemedicine could provide an alternative method of delivery of mental health services to combat the shortage of mental health providers.Footnote 64 In the wake of the opioid crisis, the Trump Administration advocated for a proposal for “[expanding] access to telemedicine services, including services involving remote prescribing of medicine commonly used for substance abuse or mental health treatment,” to combat the opioid crisis.Footnote 65
A decade after the passage of the RH Act, President Trump signed the Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018 (“the SUPPORT Act”) as a federal response to the nation's opioid crisis.Footnote 66 The law contains a commitment to telemedicine which includes establishing the very same regulations for the special registration that had already been required a decade before in the RH Act.Footnote 67 Section 3232 of the SUPPORT Act sets a deadline for the Attorney General to activate the provision for special registration for telemedicine specified in the RH Act no later than one year after the date of enactment.Footnote 68 The guidance for the special registration was supposed to become effective on October 24, 2019.Footnote 69 In January 2019, the ATA sent a letter to the DEA pressing the agency to issue the regulations for the special registration.Footnote 70 The letter contained a number of recommendations by ATA for implementation of the special registration.Footnote 71 Similarly, in September 2019, the Center for Telehealth & e-Health Law (“CTeL”) also urged the DEA's guidance for implementation of the special registration.Footnote 72 Although the original October deadline came and passed, the DOJ released notice of regulations to implement the special registration process in November 2019.Footnote 73 As of the writing of this article in January 2020, the special registration has still not been implemented, with members of Congress calling for the DEA to take immediate action and fulfill this obligation under law.Footnote 74
VI. UNDERSTANDING STATE LAWS ON TELEMEDICINE
The current lack of a national telemedicine law or federal regulation has left the states with the ability to create their own ways of regulating the many legal issues involved with telemedicine. This begins with the very definition of telemedicine.
A. Defining “Telemedicine” and “Telehealth”
According to the Center for Connected Health Policy, there are a number of ways that state laws on telemedicine differ.Footnote 75 However, there is evidence of recognizable similarities.Footnote 76 “Although each state's laws, regulations, and Medicaid program policies differ significantly, certain trends are evident.”Footnote 77
At the core of the state laws is how precisely the terms “telemedicine” and “telehealth” are defined, and this currently serves as an area of difference across states.Footnote 78 The Center for Connected Health Policy explains these differences and their origins as follows:
No two states are alike in how telehealth is defined and regulated. While there are some similarities in language, perhaps indicating states may have utilized existing verbiage from other states, noticeable differences exist. These differences are to be expected, given that each state defines its Medicaid policy parameters, but it also creates a confusing environment for telehealth participants to navigate, particularly when a health system or practitioner provides health care services in multiple states.Footnote 79
As discussed in a previous section, “telemedicine” and “telehealth” have been defined in a variety ways by different medical organizations.Footnote 80 Similarly, the actual legal definitions of these terms and related terminology also differs by state.Footnote 81 This can be summarized in the following way:
States alternate between using the term “telemedicine” or “telehealth”. In some states both terms are explicitly defined in law and/or policy and regulations. “Telehealth” is sometimes used to reflect a broader definition, while “telemedicine” is used mainly to define the delivery of clinical services. Additional variations of the term, primarily utilizing the “tele” prefix are also becoming more prevalent. For example, the term “telepractice” is being used frequently as it relates to physical and occupational therapy, behavioral therapy, and speech language pathology. “Telepsychiatry” is also a term commonly used as an alternative when referring specifically to psychiatry services.Footnote 82
Starting with the very premise that there is difference at the state level in defining “telemedicine,” “telehealth,” and the related terms provides the context for the complexity of regulation in this area where healthcare meets technology.
B. Online Prescribing
Online prescribing has become a greater phenomenon in states in light of the lack of movement by the DEA over the special registration and the need to be able to provide telemedicine services for mental health generally and especially in light of the opioid crisis.Footnote 83 Just as state laws differ in how they define and use the terms “telehealth” and “telemedicine,” they also have taken different approaches to addressing online prescribingFootnote 84 This means that “there are a number of nuances and differences across the states related to the use of technology and prescribing.”Footnote 85 According to the Center for Connected Health Policy, the majority of states do not consider only the use of an internet/online questionnaire as sufficient to establish the patient-provider relationship necessary for prescribing.Footnote 86 “One of the primary considerations is whether an online consultation is adequate enough to establish a patient-provider relationship when one did not exist before. Until that relationship is established, a prescription cannot be made.”Footnote 87 A physical examination may be another requirement prior to engaging in online prescribing.Footnote 88 However, states vary as far as whether the examination must be conducted in person or virtually.Footnote 89
Increasingly, the issue of online prescribing of controlled substances has become a hotly debated issue and states have taken differing approaches to address it.Footnote 90 Primarily three different approaches have developed by states in response to online prescribing: (1) some states prohibit online prescribing of controlled substances and/or have limited exceptions for allowing them to be prescribed, (2) another set of states allow remote online prescribing, and (3) the final category of states also allow online prescribing but impose additional restrictions on the providers.Footnote 91 Some states prohibit online prescribing of controlled substances.Footnote 92 However, the opioid crisis has led several states to take a more relaxed regulatory approach to online prescribing.Footnote 93 Further, several states have moved to allow online prescribing of controlled substances under state law within the current limitations of federal law.Footnote 94
VII. BALANCING ACCESS TO CARE AND QUALITY OF CARE
The development of telemedicine and online prescribing laws has turned on defining what is sufficient to establish the patient-physician relationship. As technology and telemedicine continue to change the delivery of health care, the question is now whether the patient-physician relationship continues to require an in-person examination. Is the quality of the care provided diminished when an in-person evaluation does not occur? The use of telemedicine certainly eliminates the ability of a physician to touch a patient to potentially detect some symptoms which will be lost in the use of telemedicine. But can or should the in-person evaluation requirement be maintained in the traditional sense or does it need to be modified to allow telemedicine to flourish? How does this relate to the issue of prescribing specifically? Will too much be lost in the patient-physician relationship by eliminating or modifying the in-person evaluation requirement?
The American College of Physicians (“ACP”) has been weighing in on this very issue for some time, which it describes as attempting to strike a balance between health care access and quality.Footnote 95 In January 2019, the ACP released the 7th Edition of its Ethics Manual stating the following position regarding the patient-physician relationship involving telemedicine and the role of in-person encounters:
In the context of telemedicine, there must be a valid patient–physician relationship for a professionally responsible telemedicine service to take place. A telemedicine encounter itself can establish a patient–physician relationship through real-time, technically appropriate audiovisual technology. When there has been no direct previous contact or existing relationship with a patient before a telemedicine encounter, the physician must take appropriate steps to establish a relationship based on the standard of care required for an in-person visit, or consult with another physician who does have a relationship with the patient. The benefits of opportunities for increased access to care through telemedicine “must be balanced according to the nature of the particular encounter and the risks from the loss of the in-person encounter (such as the potential for misdiagnosis; inappropriate testing or prescribing; and the loss of personal interactions that include the therapeutic value of touch, communications with body language, and continuity of care).”Footnote 96
Thus, the ACP promotes that it is ethically acceptable to establish a patient-physician relationship in the context of telemedicine without the traditional in-person evaluation if audiovisual technology is utilized. The ACP emphasizes the critical importance of medical professionals being mindful of the necessary balance between the access that telemedicine creates to medical care with the potential losses that can come from its use.
The ACP Manual further emphasizes that the responsibilities of the physician to the patient still exist even in the absence of an in-person encounter.Footnote 97 The ACP Manual is particularly clear that prescribing is ethically prohibited when it is done only on the basis of an online questionnaire or telephone communication.Footnote 98 The Manual does provide exceptions such as public health emergencies.Footnote 99
However, the ACP does take a more critical position regarding the use of e-mail and telephone communications.Footnote 100 As communication is a critical component of the patient-physician relationship, the ACP takes the view that communication via e-mail and telephone can be used as means to supplement the patient-physician relationship but should not serve as the basis of this relationship.Footnote 101
The ACP is not the only medical group which has taken positions regarding the ethics of physicians' responsibilities when telemedicine is utilized in the delivery of health care. In 2016, the American Medical Association (“AMA”) also weighed in on ethics of the practice of medicine when telemedicine is used.Footnote 102 Similarly, the AMA acknowledged that the use of telemedicine does not change a physician's responsibilities to a patient and that ultimately the same ethical obligations are required of the physician in this context:
Although physicians' fundamental ethical responsibilities do not change, the continuum of possible patient-physician interactions in telehealth/telemedicine give rise to differing levels of accountability for physicians.Footnote 103
Additionally, the AMA guidance points out the responsibility the physician utilizing telemedicine has in making informed decisions in this context in light of a lack of in-person examination which certainly touches on the issue of prescribing.Footnote 104 A specific set of guidance is included that goes to the physician's responsibilities in prescribing.Footnote 105
VIII. CRAFTING INNOVATIVE LEGISLATIVE RESPONSES
A. Revaluating the In-Person Encounter Requirement
The controversy over the in-person encounter requirement is now at the center of telemedicine policy debates.Footnote 106 This is especially true regarding online prescribing. Some states have moved away from requiring the traditional in-person encounter to at least favoring a modification of this requirement to allow an audiovisual encounter in the alternative.Footnote 107 Some argue that this modification still hampers access to telemedicine because it prevents other types of online encounters, such as online questionnaires, from establishing a relationship.Footnote 108 Despite this, allowing an audiovisual encounter to meet the traditional in-person encounter requirement seems to be the most advantageous at this point to attempt to strike the balance between access and quality when telemedicine is utilized. If the DEA moves forward with the special registration, this could open the door wide for online prescribing. As the ACP and AMA both view the audiovisual encounter as sufficient to establish the patient-provider relationship, this seems to be the right direction for the law to also embrace with the knowledge that physicians are still held to their traditional ethical duties in the practice of medicine in the telemedicine context.
B. Insufficient Medical Information
Another source of the concern that telemedicine may contribute to overprescribing is the lack of medical information the provider may have when treating a patient, especially if there has been no prior relationship. More seems needed to strike the balance here between access to health care and quality of care. One potential avenue may be to incorporate into the law a requirement for the telemedicine provider to obtain a signed release of medical information from the patient prior to the telemedicine encounter if the patient has already established a relationship with another physician or when the patient has no previous relationship with the telemedicine provider. In light of the study on children and overprescribing in the DTC context, this may be a necessary safeguard for pediatric care.Footnote 109 Access to more medical information and greater understanding of a patient's medical history may prevent overprescribing in telemedicine.
C. Identification Verification
Although it may not per se contribute to overprescribing in telemedicine at this point, issues with patient identification and verification could lead to the potential for overprescribing in the telemedicine context in particular. With the introduction of telemedicine, inaccurate patient identification and verification could lead to medical identity theft and potential patient safety risk. Because of this, policy and regulations must address these issues to ensure that proper patient identification and verification occur. One potential recommendation would be a national patient database in which telemedicine providers would register patients. This could also track the frequency of telemedicine visits to ensure patients do not bounce around to different telemedicine providers within a short period of time which would also help prevent the potential incidence of overprescribing.
D. Greater Regulation of DTC
A final consideration is for the federal government to provide national regulation on DTC telemedicine companies. There is evidence that the DTC model opens the door to greater incidence of both overprescribing and inappropriate prescribing.Footnote 110 The variety of state laws complicate this significantly, leading to the conclusion that implementing national regulations would be of great benefit.Footnote 111
IX. CONCLUSION
Technology is drastically changing the landscape of the delivery of health care through the use and practice of telemedicine. The law has not kept pace with the rapid movement of technology which will only continue to evolve. As online prescribing demonstrates, issues continue to emerge and the medical profession must consider the role that ethics plays in the delivery of health care when new technologies are involved. What is clear is that the ethical responsibilities of physicians cannot be ignored when it comes to drafting and implementing legislation addressing emerging issues in telemedicine. While it is critical to expand and improve access to health care for all, this cannot be done in a vacuum without considering quality and patient protection. Shedding light on online prescribing in telemedicine demands that policy decisions embrace the role of telemedicine in improving access to care while also ensuring that quality is not compromised by not overly limiting the requirements on physicians. As technology becomes an integral part of the delivery of health care, the law can be used as a valuable tool to ensure a necessary balance between regulating the telemedicine market and expanding quality access to health care.
Dr. Hoffman wishes to thank her parents, Ronald and Janet Hoffman for their continual support. A special thank you to Sara Klein, LL.B., M.I., Faculty Services Librarian, Peter W. Rodino, Jr. Law Library, Center for Information and Technology at Seton Hall University School of Law for her assistance. Dr. Hoffman can be reached at Laura.Hoffman@shu.edu.
